Aggregated China Business Blogs



GlaxoSmithKline Invests in Move from 'Made in China' to 'Discovered in China'

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
December 14, 2007|


Earlier this year, GlaxoSmithKline (GSK) announced it would invest $40 million to establish a neurological R&D center in Shanghai’s Zhangjiang Hi-Tech Park (see story). GSK is now even more committed to its China R&D efforts: the company says it will spend $100 million by the end of 2008 on this same facility, which will have 1,000 staff members in place by the end of 2010.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • GlaxoSmithKline to Double China R&D Staff
  • GSK in $100m China push
  • Apple China Changes Appearance Of Official Website
  • Why is LDK Solar Constantly Beaten Down?
  • Chinalco's $14bn move shows political savvy

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |